Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Familial partial lipodystrophy | D052496 | — | — | — | 1 | — | — | — | 1 |
Type 2 diabetes mellitus | D003924 | EFO_0001360 | E11 | — | 1 | — | — | — | 1 |
Non-alcoholic fatty liver disease | D065626 | EFO_0003095 | K75.81 | — | 1 | — | — | — | 1 |
Hypertriglyceridemia | D015228 | EFO_0004211 | — | — | 1 | — | — | — | 1 |
Hyperlipoproteinemia type v | D006954 | Orphanet_70470 | E78.3 | — | 1 | — | — | — | 1 |
Hyperlipoproteinemia type i | D008072 | Orphanet_411 | E78.3 | — | 1 | — | — | — | 1 |
Hyperlipidemias | D006949 | HP_0003077 | E78.5 | — | 1 | — | — | — | 1 |
Dyslipidemias | D050171 | HP_0003119 | — | — | 1 | — | — | — | 1 |
Hyperlipoproteinemias | D006951 | HP_0010980 | — | — | 1 | — | — | — | 1 |
Hyperlipoproteinemia type ii | D006938 | EFO_0004911 | E78.00 | — | 1 | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Healthy volunteers/patients | — | — | — | 2 | — | — | — | — | 2 |
Drug common name | VUPANORSEN |
INN | vupanorsen |
Description | Vupanorsen is an oligonucleotide pharmaceutical. It is currently being investigated in clinical studies. |
Classification | Oligonucleotide |
Drug class | antisense oligonucleotides |
Image (chem structure or protein) | ![]() |
Structure (InChI/SMILES or Protein Sequence) | — |
PDB | — |
CAS-ID | — |
RxCUI | — |
ChEMBL ID | CHEMBL4298197 |
ChEBI ID | — |
PubChem CID | — |
DrugBank | — |
UNII ID | A7YG62NHZ6 (ChemIDplus, GSRS) |